Posts in the “Non Small Cell Lung Cancer Non Small Cell Lung Cancer” category:

Herbst Tackles Key Questions in Emerging PD-1/PD-L1 Immunotherapy for NSCLC

Posted by Samantha Powell on August 2nd, 2014 |

Emerging agents and pressing research questions in immunotherapy were reviewed in depth during the 15th Annual International Lung Cancer Congress, with Roy S. Herbst, MD, PhD, of the Yale Cancer Center, leading the way. Herbst was the recipient of the 2014 Addario Lectureship Award, which the Bonnie J. Addario Lung Cancer Foundation bestows annually at […]

Possible Advance for Some Late-Stage Lung Cancer Patients

Posted by Samantha Powell on July 8th, 2014 |

Surgical biopsy is safe for certain late-stage lung cancer patients and could improve their chances of getting treated with newer types of drugs that target cancer-related genetic mutations, a new small study reveals. In many cases, surgical biopsy is too dangerous for these patients, so less-invasive methods are used, including fine-needle aspiration and core needle […]

Brachytherapy with Sublobar Resection Fails to Improve NSCLC Recurrence Rates

Posted by Samantha Powell on July 4th, 2014 |

Brachytherapy did not reduce rates of local recurrence after sublobar resection in patients with non–small-cell lung cancer (NSCLC), according to results of a new randomized phase III study. Previous work has suggested an association between sublobar resection and higher locoregional recurrence rates compared with lobectomy; as a result, the procedure is usually reserved for high-risk […]

Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment – KOL Insight

Posted by Samantha Powell on June 10th, 2014 |

Change is coming to the NSCLC treatment algorithm—and it’s coming soon. Revolutionary new immunotherapies, more personalised treatment choices and further drug developments are all set to roll out in the near future. What are the potential blockbusters, who will gain approvals first and what are the future challenges? Drivers of change – Revolutionary immunotherapies. From […]

New gene tests may give cancer patients quicker path to treatment

Posted by Samantha Powell on June 6th, 2014 |

A new way of evaluating tumors may soon help cancer patients identify the underlying genetic link to their disease – and the best possible treatment – all in a single test. Researchers are set to begin clinical trials using a more comprehensive testing method that looks for all of the known genes that may be […]

New Video Delves Into the Promise of Lung Cancer Immunotherapy Clinical Trials for Patients With Non-Small Cell Lung Cancer

Posted by Samantha Powell on May 15th, 2014 |

Date: 5/15/14 Outlet Full Name: Digital Journal Author: No author http://www.digitaljournal.com/pr/1922309 A recently released video on cancer immunotherapy is offering new hope to patients with non-small cell lung cancer (NSCLC), the type of cancer which makes up 85% to 90% of all lung cancer cases in the US and claims more lives each year than […]

Experts Weigh in on Managing Elderly Patients With NSCLC

Posted by Samantha Powell on May 6th, 2014 |

News Headline: Experts Weigh in on Managing Elderly Patients With NSCLC Date: 5/6/14 Outlet Full Name: Oncology Nurse Advisor Author: Kathy Boltz http://www.oncologynurseadvisor.com/experts-weigh-in-on-managing-elderly-patients-with-nsclc/article/345598/ Approximately half of all patients with a diagnosis of non-small cell lung cancer (NSCLC) are age 70 years or older, yet despite this high percentage, elderly patients are not well represented in […]

Maintenance Therapy in Non- Small Cell Lung Cancer

Posted by Samantha Powell on May 5th, 2014 |

News Headline: Maintenance Therapy in Non- Small Cell Lung Cancer Date: 5/5/14 Outlet Full Name: Oncology Live Author: Mark Kris, Corey Langer, Benjamin Levy, Mark Socinski, Heather Wakelee http://www.onclive.com/peer-exchange/nsclc-outcomes/Maintenance-Therapy-in-Non-Small-Cell-Lung-Cancer A preponderance of evidence supports the utilization of some form of maintenance therapy for patients with metastatic non-small cell lung cancer (NSCLC). Benjamin P. Levy, MD, […]

Inhibition of Lactate Enzyme Prevents Expansion of Aggressive Cancer Initiating Cells In Lung Cancer Model

Posted by Samantha Powell on April 14th, 2014 |

Date: 4/14/14 Outlet Full Name: Medical News Today Author: No author http://www.medicalnewstoday.com/releases/275394.php Cancer cells generate energy differently than normal cells, a characteristic that helps them to survive and metastasize. A major goal in the field of cancer metabolism is to find ways to overcome this survival advantage. Now a research team led by investigators in […]

New Drug Successful Against Crizotinib – Resistant, ALK- Positive Lung Cancer

Posted by Samantha Powell on April 14th, 2014 |

Date: 4/14/14 Outlet Full Name: Oncology Nurse Advisor Author: Kathy Boltz http://www.oncologynurseadvisor.com/new-drug-successful-against-crizotinib-resistant-alk-positive-lung-cancer/article/342459/ Although crizotinib, a targeted cancer treatment, is very effective in causing rapid regression of a particular form of lung cancer, patients’ tumors inevitably become resistant to the drug. Now a new drug, ceritinib, appears to be effective against advanced ALK-positive non-small cell lung […]